Narcan is contraindicated for resp depression not due to opioid ingestion. Side effects include tachycardia, hypertension, N/V, seizures, even cardiac arrest. Do you really want to cause these side effects on someone who could quite possibly be having a CVA?
CONTRAINDICATIONS — Hypersensitivity to naloxone or any component of the formulation
WARNINGS / PRECAUTIONS
Concerns related to adverse effects:
Acute opioid withdrawal: May precipitate symptoms of acute withdrawal in opioid-dependent patients, including pain, hypertension, sweating, agitation, irritability; in neonates: shrill cry, failure to feed. Carefully titrate dose to reverse hypoventilation; do not fully awaken patient or reverse analgesic effect (postoperative patient).
Disease-related concerns:
Cardiovascular disease: Use with caution in patients with cardiovascular disease or in patients receiving medications with potential adverse cardiovascular effects (eg, hypotension, pulmonary edema or arrhythmias); pulmonary edema and cardiovascular instability, including ventricular fibrillation, have been reported in association with abrupt reversal when using narcotic antagonists. Administration of naloxone causes the release of catecholamines; may precipitate acute withdrawal or unmask pain in those who regularly take opioids.
Seizures: Use caution in patients with history of seizures; avoid use in treatment of meperidine-induced seizures.
Other warnings/precautions:
Opioid overdose: Recurrence of respiratory depression is possible if the opioid involved is long-acting; observe patients until there is no reasonable risk of recurrent respiratory depression.
Postoperative reversal: Appropriate use: Excessive dosages should be avoided after use of opiates in surgery. Abrupt postoperative reversal may result in nausea, vomiting, sweating, tachycardia, hypertension, seizures, and other cardiovascular events (including pulmonary edema and arrhythmias).
(Taken from the following references
REFERENCES
American Academy of Pediatrics Committee on, Drugs. Naloxone Dosage and Route of Administration for Infants and Children: Addendum to Emergency Drug Doses for Infants and Children. Pediatrics 1990; 86:484.
American Heart Association Emergency Cardiovascular Care, Committee. 2005 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC), Part 10.2: Toxicology in ECC. Circulation 2005; 112(24 Suppl):IV126.
American Heart Association Emergency Cardiovascular Care, Committee. 2005 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC), Part 12: Pediatric Advanced Life Support. Circulation 2005; 112(24 Suppl):IV167.
Bergasa, NY, Alling, DW, Talbot, TL, et al. Effects of Naloxone Infusions in Patients With the Pruritus of Cholestasis. A Double-Blind, Randomized, Controlled Trial. Ann Intern Med 1995; 123:161.
Boeuf, B, Gauvin, F, Guerguerian, AM, et al. Therapy of Shock With Naloxone: A Meta-Analysis. Crit Care Med 1998; 26:1910.
Chamberlain, JM, Klein, BL. A Comprehensive Review of Naloxone for the Emergency Physician. Am J Emerg Med 1994; 12:650.
Drugs for Pediatric Emergencies. Pediatrics 1998; 101:E13.
Goldfrank, L, Weisman, RS, Errick, JK, et al. A Dosing Nomogram for Continuous Infusion Intravenous Naloxone. Ann Emerg Med 1986; 15:566.
Hantson, P, Evenepoel, E, Ziade, D, et al. Adverse Cardiac Manifestations Following Dextropropoxyphene Overdose: Can Naloxone Be Helpful. Ann Emerg Med 1995; 25:263.
Hoffman, RS, Goldfrank, LR. The Poisoned Patient With Altered Consciousness. Controversies in the Use of a'Coma Cocktail'. JAMA 1995; 274:562.
Johnson, C, Mayer, P, Grosz, D. Pulmonary Edema Following Naloxone Administration in a Healthy Orthopedic Patient. J Clin Anesth 1995; 7:356.
Kaplan, JL, Marx, JA, Calabro, JJ, et al. Double-Blind, Randomized Study of Nalmefene and Naloxone in Emergency Department Patients With Suspected Narcotic Overdose. Ann Emerg Med 1999; 34:42.
Kendrick, WD, Woods, AM, Daly, MY, et al. Naloxone Versus Nalbuphine Infusion for Prophylaxis of Epidural Morphine-Induced Pruritus. Anesth Analg 1996; 82:641.
Kjellberg, F, Tramer, MR. Pharmacological Control of Opioid-Induced Pruritus: A Quantitative Systematic Review of Randomized Trials. Eur J Anaesthesiol 2001; 18:346.
Merigian, KS. Cocaine-Induced Ventricular Arrhythmias and Rapid Atrial Fibrillation Temporally Related to Naloxone Administration. Am J Emerg Med 1993; 11:96.
Mokhlesi, B, Leikin, JB, Murray, P, et al. Adult Toxicology in Critical Care: Part II: Specific Poisonings. Chest 2003; 123:897.
National Comprehensive Cancer Network, (NCCN). Clinical Practice Guidelines in Oncology ™ : Adult Cancer Pain. Version 1 2008. Available at
http://www.nccn.org/professionals/physician_gls/PDF/pain.pdf;
O'Connor, PG, Kosten, TR. Rapid and Ultrarapid Opioid Detoxification Techniques. JAMA 1998; 279:229.
Olsen, KS. Naloxone Administration and Laryngospasm Followed by Pulmonary Edema. Intensive Care Med 1990; 16:340.
O'Malley-Dafner, L, Davies, P. Naloxone-Induced Pulmonary Edema. Am J Nurs 2000; 100:24AA.
Pasero, C, McCaffery, M. Reversing Respiratory Depression With Naloxone. Am J Nurs 2000; 100:26.
Salvucci AA, Jr, Eckstein, M, Iscovich, AL. Submental Injection of Naloxone. Ann Emerg Med 1995; 25:719.
Storrow, AB, Wians FH, Jr, Mikkelsen, SL, et al. Does Naloxone Cause a Positive Urine Opiate Screen. Ann Emerg Med 1994; 24:1151.
Tandberg, D, Abercrombie, D. Treatment of Heroin Overdose With Endotracheal Naloxone. Ann Emerg Med 1982; 11:443.
Trujillo, MH, Guerrero, J, Fragachan, C, et al. Pharmacologic Antidotes in Critical Care Medicine: A Practical Guide for Drug Administration. Crit Care Med 1998; 26:377.
Waters, C. Cognitive Enhancing Agents: Current Status in the Treatment of Alzheimer's Disease. Can J Neurol Sci 1988; 15:249.
I didn't see anywhere about withholding naloxone dude to respiratory depression not caused by opioids...and furthermore, without proper laboratory screening, you wouldn't be able to tell if was or wasn't due to opiods unless naloxone is a administered and a + effect is noted or not.
Also, the side effects you mentioned are probably (as explained above) sympotomatic of acute withdrawal sx from the naloxone, and not from naloxone itself